中国医学创新Issue(2)：15-17,3.DOI:10.3969/j.issn.1674-4985.2016.02.005
307例鲍氏不动杆菌的临床分布与耐药性分析
Analysis of Clinical Distribution and Drug Resistance of Acinetobacter Baumannii in 307 Cases
摘要
Abstract
Objective:To understand and analyze the clinical distribution and drug resistance of acinetobacter baumannii in order to provide scientific basis for the clinical rational use of antibacterial drugs and treatment.Method:The cases who were diagnosed with infection of acinetobacter baumannii from January 2014 to December 2014 were investigated retrospectively.The bacteria was separated according to the national clinical inspection procedures.K-B method recommended by American clinical laboratory standardization institute(CLSI) was used for drug sensitive test.Result:A total of 307 strains of acinetobacter baumannii were isolated.They were from all kinds of clinical specimens,the separation rate of the sputum specimen was the highest,accounted for 90.55%,the following was clean midstream urine and secretion,accounted for 6.84% and 1.63% respectively. The drug resistance rates of acinetobacter baumannii to Minocycline,Cefoperazone/Sulbactam,Meropenem were lower,accounted for 3.91%,5.86% and 7.17% respectively.307 strains of acinetobacter baumannii were mainly distributed in the internal medical system,including respiratory medicine 90 strains,accounted for 29.32%,followed by neurology 62 strains(20.20%),geriatrics department 56 strains(18.24%),ICU 50 strains(16.29%),thoracic surgery 34 strains(11.07%),other departments 15 strains(4.89%). Conclusion:Acinetobacter baumannii is one of the common pathogenic bacteria of hospital infection.We shall strengthen the monitoring of drug resistance of acinetobacter baumannii,grasp its trend of drug resistance,correct the phenomenon of irrational use of antibiotics,actively take effective control measures and avoid the incidence of superbugs with generic drug resistant.关键词
鲍氏不动杆菌/临床分布/耐药性Key words
Acinetobacter baumannii/Clinical distribution/Drug resistance引用本文复制引用
丁淑红,穆金智..307例鲍氏不动杆菌的临床分布与耐药性分析[J].中国医学创新,2016,(2):15-17,3.基金项目
内蒙古科技厅基金项目 （）
